Björklund Pharma

  • Home
  • Company
  • Science & Innovation
  • Publications
  • Media
  • Contact
    • Contact Form

Collaborations

Björklund Pharma is a dynamic and ambitious early-stage biopharmaceutical company born out of the need to respond to market demands. In an increasingly globalized world, we believe in the ability to cross frontiers and sustainable growth based on cooperation, commitment, and trust. Björklund Pharma is proud to build strong relationships with patients, researchers, and business communities. Feel free to contact us for further information or discuss a possible collaboration.

Contact

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment

RSS CONEM Autism Research

  • Zinc, Copper, and Autism Spectrum Disorder
  • Digestive Enzyme Therapy: A Possible Option in Autism Spectrum Disorder
  • Vitamin D Deficiency Correlates with Severity of Autism and Shows Improvement with Supplementation
  • ADHD, Autism, and Phenylketonuria
  • Serum Zinc and Copper Levels in Autistic Children

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2023 Björklund Pharma AS